(Q53040507)

English

Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.

scientific article published on 20 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

object named as

Hyeon-Seok Eom

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

14

object named as

Cheolwon Suh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Seok Jin Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Deok-Hwan Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jin Seok Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jae-Yong Kwak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Dae Sik Hong

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jong Ho Won

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jae Hoon Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Dok Hyun Yoon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Taek-Keun Nam

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sang-Wook Lee

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Yong Chan Ahn

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Won Seog Kim

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

20 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1895-1901

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Treatment of localized extranodal NK/T cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2137-6

21 January 2018

Identifiers

10.1007/S00277-014-2137-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947798%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53040507&oldid=1812396133"